You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
9 July 2015
Genmab Announces Completion of Rolling Submission of Biologics License Application for Daratumumab in Multiple Myeloma and Achievement of a USD 15 Million Milestone
7 July 2015
Genmab Announces European Regulatory Submission for Ofatumumab as Maintenance Therapy for Relapsed CLL
11 June 2015
Grant of Warrants to Genmab Employees
5 June 2015
Genmab Announces Start of Rolling Submission of Biologics License Application for Daratumumab for Double Refractory Multiple Myeloma to the FDA
2 June 2015
Genmab Gains License to Antibody Panel Targeting CD19
20 May 2015
Report Pursuant to Section 28a of the Danish Securities Trading Act